Association of Plasma Amyloid, P-Tau, GFAP, and NfL With CSF, Clinical, and Cognitive Features in Patients With Dementia With Lewy Bodies.
Katharina BolsewigAnnemartijn A J M van UnnikElena R BlujdeaMaria C GonzalezNicholas James AshtonDag AarslandHenrik ZetterbergAlessandro PadovaniLaura BonanniBrit MollenhauerSebastian SchadeRik VandenbergheKoen PoesenMilica G KrambergerClaire PaquetOlivier BousigesBenjamin CretinEline A J WillemseCharlotte E TeunissenAfina W Lemstranull nullPublished in: Neurology (2024)
Our study suggests a possible utility of plasma Aβ42/40, P-tau181, and P-tau231 as a noninvasive biomarkers to assess amyloid copathology in DLB, and plasma GFAP and NfL as monitoring biomarkers for cognitive symptoms in DLB.